FibroGen Inc (NAS:FGEN)
$ 0.58 0.001 (0.17%) Market Cap: 58.45 Mil Enterprise Value: 48.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Q1 2021 FibroGen Inc Earnings Call Transcript

May 10, 2021 / 09:00PM GMT
Release Date Price: $19.42 (-4.00%)
Operator

Good day, and welcome. Thank you for standing by. Welcome to the FibroGen First Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker for today, Mr. Michael Tung. Please go ahead.

Michael Tung
FibroGen, Inc. - IR Executive

All right. Thank you, Erica, and good afternoon, everyone, and welcome to FibroGen's conference call for our fiscal 2021 first quarter. I'm Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen.

Joining me on today's call are Enrique Conterno, our Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China Operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety and Pharmacovigilance. Format for today's call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot